コーパス検索結果 (left1)
通し番号をクリックするとPubMedの該当ページを表示します
1 ME is comprised of four genes in two adjacent operons, w
2 ME models present considerable computational challenges:
3 ME recruitment of leukocytes was delayed but persisted f
4 ME seems to be a common complication of longstanding OT
5 ME-Class is thus a powerful tool to identify genes that
6 ME-ECTs displayed the lowest dead cell ratio (p < 0.001)
7 ME-induced MOPr desensitization and resensitization did
8 ME-SIMS analysis followed by t-distributed stochastic ne
9 erity and fatigue duration, cytokines of 192 ME/CFS patients and 392 healthy controls were measured u
11 y small interfering RNA (siRNA) eliminates 2-ME-induced arrest and introducing AR into PC3-M cells co
12 ravitreal injection of 2-Methoxyestradiol (2-ME) nanoemulsion in regressing neovascularization of a R
14 uced in 21 rats then two concentrations of 2-ME nanoparticles were injected in right eyes of 14 rats
17 subunit-containing GABAA receptors in adult ME mice specifically reduces the cross-modal aspect of r
19 xtensive recovery of cortical activity after ME fails as a result of suppression or functional immatu
21 tward current produced by the opioid agonist ME was concentration dependent, reversed at the potassiu
23 ion beam-induced fragmentation of analytes, ME-SIMS has proven useful for detection of numerous bior
24 ty eyes of 60 patients with CRVO or BRVO and ME and 40 healthy subjects underwent measurements of sup
29 le the tunabilities of the magnetization and ME coupling due to the control of the charge transfer.
31 er increases Ser5P-RNAPII at LEF-1 sites and ME gene promoters, indicating that elongation remains li
33 ,290 isolates the CA was 97.1% (0.2% VME and ME, 2.5% minor errors) using anidulafungin as the surrog
35 ctric signals associated with an antiferroic ME-active magnetic quadrupole order in the real material
36 halamic arcuate-median eminence complex (Arc-ME) controls energy balance, fertility and growth throug
37 e identify 50 transcriptionally distinct Arc-ME cell populations, including a rare tanycyte populatio
39 luding a rare tanycyte population at the Arc-ME diffusion barrier, a new leptin-sensing neuron popula
42 bination was recorded following PeT for beta-ME ( approximately 100%), for Trolox, n-propyl gallate,
43 ng agents, namely beta-mercaptoethanol (beta-ME), Trolox (TX), n-propyl gallate (n-PG), and ascorbic
48 We concluded that killing of S. mutans by ME promotes effective remineralization of S. mutans-demi
49 ess of chemical or mechanical exfoliation (C/ME) followed by a rapid densification and restacking of
55 ed a multiepitope citrullinated peptide (Cit-ME), derived from major prevalent citrullinated autoanti
56 vant-induced arthritis rats treated with Cit-ME, disease severity was significantly reduced compared
57 lation-based Gene Expression Classification (ME-Class), to explain specific variation in methylation
61 t to be practical on large problems (current ME models have 70,000 constraints and variables and will
62 of clinical criteria are available to define ME/CFS, yet none of the current diagnostic methods have
63 ht case definitions have been used to define ME/CFS; a ninth, recently proposed by the Institute of M
64 ly lower percentage of patients demonstrated ME within 90 days after surgery with nepafenac 0.3% vers
67 ctric and magnetic moments with differential ME coefficients on the order of 10(4) ps/m are achieved.
70 role of CCL3 in OM, we evaluated middle ear (ME) responses of ccl3(-/-)mice to nontypeable Haemophilu
73 es were: patients (%) in whom macular edema (ME) developed (>/=30% increase from preoperative baselin
76 natives for the management of macular edema (ME) secondary to branch retinal vein occlusion (BRVO).
85 amplification and microchip electrophoretic (ME) separation for rapid forensic short tandem repeat (S
86 uroendocrine signals at the median eminence (ME) to control long-lasting pituitary hormone rhythms es
87 produced by premix membrane emulsification (ME) enabled to produce microcapsules containing procyani
90 The diagnosis of myalgic encephalomyelitis (ME)/chronic fatigue syndrome (CFS) is based on clinical
93 iving contrast agent, magneto-endosymbionts (MEs) derived from magnetotactic bacteria for the labelin
96 pioid agonists DAMGO or [Met(5) ]enkephalin (ME) into the KF reduced respiratory frequency and amplit
97 maximal concentrations of Met(5)-enkephalin (ME) and somatostatin (SST; coupling to native SST recept
98 n of the opioid agonist [Met(5)]-enkephalin (ME) caused significantly less desensitization in KF neur
102 ains possess the genes for the malic enzyme (ME) pathway, which allows malate to be used as a supplem
105 ry major errors [VME] and 2.6% major errors [ME]) and 84.1% for C. neoformans (4.5% VME and 11.4% ME)
107 ty for Rzhetsky and Nei's minimum evolution (ME) approach, one of the earliest methods for constructi
109 of Metabolism and macromolecular Expression (ME) compute proteome allocation linked to metabolism and
110 of metabolism and macromolecular expression (ME) significantly expand the scope and predictive capabi
113 ultrasonic (UAE) and maceration extraction (ME), MAE showed significantly (p<0.05) higher recovery o
118 en and 23 women) met diagnostic criteria for ME/CFS by Institute of Medicine, Canadian, and Fukuda cr
119 that achieves reliability and efficiency for ME models and other challenging problems tested here.
120 l growth factor (VEGF) pharmacotherapies for ME associated with CRVO, including intravitreal ranibizu
121 l growth factor (VEGF) pharmacotherapies for ME, including intravitreal bevacizumab (5), aflibercept
122 These results demonstrate the potential for ME-SIMS tandem MS development in bottom-up proteomics im
125 erapy is safe and effective over 2 years for ME associated with CRVO and that delay in treatment is a
128 rained ME model thus represents a generalist ME model reflecting both growth rate maximization and "h
132 cho-Planar J-resolved Spectroscopic Imaging (ME-EP-JRESI), was evaluated in 10 healthy controls and a
135 e solution method for growth maximization in ME models using a quad-precision NLP solver (Quad MINOS)
137 eeting different case definitions, including ME, and providing subgroup analysis are needed to fill r
140 We attribute the current-induced interface ME effect to modulations of the strong double-exchange i
142 piezoelectric and magnetostrictive laminate (ME composite) structure shows an equivalent magnetic noi
147 g SC injection into the animal thigh, the LC-MEs had more prolonged release of (99m)Tc in a first-ord
148 is results in the existence of a bulk linear ME vortex structure or a bulk ME coupling such that if P
153 and electric properties in magnetoelectric (ME) composite heterostructures is crucial for multiple t
155 near-theoretical intrinsic magnetoelectric (ME) coupling of 7 V cm(-1) Oe(-1) is achieved in a heter
157 lly actuated nanomechanical magnetoelectric (ME) antennas with a suspended ferromagnetic/piezoelectri
158 oits recent advances in the magnetoelectric (ME) composite sensors that exhibit an ultrahigh AC magne
162 hESCs) can be directed toward a mesendoderm (ME) or neuroectoderm (NE) fate, the first decision durin
165 rectangular internal staggered posts (mesh, ME), without posts (plain sheet, PS), or long parallel p
166 BSTARCT: Microbial enhanced coalbed methane (ME-CBM) recovery is critically examined as a viable tech
167 (SECM) like approach of a Pt microelectrode (ME), which was leveled with the WE toward the IRE surfac
171 VA CS and 5 of 15 (33%) receiving ChAd63-MVA ME-TRAP demonstrated a delay in time to treatment, compa
172 ce the liver parasite burden, but ChAd63-MVA ME-TRAP remains the most promising antigenic insert for
175 as a consequence of knocking out either NAD-ME or PPDK activity, particularly phosphoenolpyruvate ca
177 ppear to compensate for the reduction in NAD-ME, suggesting that NAD-ME was the key decarboxylase for
181 erature was less pronounced for PCK and NADP-ME Rubisco, which would be advantageous in warmer climat
182 The alternative malate decarboxylase, NADP-ME, did not appear to compensate for the reduction in NA
183 ucleotide (NAD) phosphate malic enzyme (NADP-ME) and phosphoenolpyruvate carboxykinase (PCK) photosyn
184 enzyme (ME) and/or cytosolic/plastidic NADP-ME combined with the cytosolic/plastidic pyruvate orthop
185 useful guide for exploring and designing new ME-active materials based on vortex-like spin arrangemen
186 Morphine-induced desensitization (but not ME) was reduced by protein kinase C inhibition in wild-t
192 etinal vascular permeability, development of ME, and morphological characteristics including acellula
194 questionnaires to measure illness domains of ME/CFS and to evaluate patient heterogeneity overall and
196 are effective and safe for the management of ME associated with BRVO; however, corticosteroids are as
197 eatment was associated with a higher odds of ME resolution (OR, 3.59; 95% CI, 2.22-5.80; P < .001) an
198 ted out 2 clusters with a low probability of ME resistance and 4 with a high probability of PT, CE, a
199 ll previously implicated in the promotion of ME in ischemic retinal disease, were not elevated by qua
200 ive donor recipients with upper quartiles of ME use, compared with 92.0% among those who did not rece
205 ctivin-induced SMADs to activate a subset of ME genes that is required to form cardiac mesoderm.
209 tokine's preprocessed data were regressed on ME/CFS severity plus covariates for age, sex, race, and
212 phiphile required to form microemulsion (Phi(ME)), which was the analytical signal of the method.
215 ehicle in reducing the risk of postoperative ME, with the integrated analysis showing improved BCVA a
216 data suggest that patients with postsurgical ME should initially be treated with ketorolac and PA qid
220 issues from the Roadmap Epigenomics Project, ME-Class significantly outperforms standard methods usin
223 ate that these fast and numerically reliable ME solution methods will accelerate the wide-spread adop
225 nalysis of the trajectories, "localized RRKM-ME" and "competitive localized noncanonical" rate models
232 d in a subset of ERM patients who had severe ME (central subfield thickness >/=450 mum on spectral do
234 ix-enhanced secondary ion mass spectrometry (ME-SIMS) has overcome one of the biggest disadvantages o
235 ix-enhanced-secondary ion mass spectrometry (ME-SIMS) to investigate the lipid profiles of neuronal c
236 cal ME stratified into post-cataract surgery ME (PCSME) and post-other surgery ME (POSME) were random
237 ct surgery ME (PCSME) and post-other surgery ME (POSME) were randomized to ketorolac 4 times a day (q
240 eport here the first demonstration of tandem ME-SIMS for de novo sequencing of endogenous neuropeptid
241 tment of cross-modal recovery upon long-term ME coincides with the transition from adolescence to adu
243 onocular and binocular cortices to long-term ME or dark exposure or a combinatorial deprivation revea
244 he Tobacco, Exercise and Diet Messages (TEXT ME) trial was a parallel-group, single-blind, randomized
246 the present study, after demonstrating that ME kills >99% of S. mutans in planktonic cultures, 8 ena
251 tegration time window is detected across the ME and consists of high-frequency DA discharges that are
253 al/spectral profiles of metabolites from the ME-EP-JRESI sequence were in good agreement with that of
258 f SECM and revealed the contact point of the ME and WE on the IRE, which was used as reference point
266 e have implemented, validated and tested the ME-EP-JRESI sequence, demonstrating that multi-echo acqu
275 mong the subset with VA <20/40 attributed to ME, 33.1% (95% CI, 25.2-42.7) improved to >/= 20/40.
279 tion computes steady-state flux solutions to ME models, but flux values are spread over many orders o
282 f pharmacologic therapeutic options to treat ME in patients with ERMs, we examine here the expression
287 a single tertiary referral center for which ME was the principal cause of reduced visual acuity.
288 of serum cytokines could be associated with ME/CFS and correlated with disease severity and fatigue
289 ant upward linear trend that correlated with ME/CFS severity: CCL11 (Eotaxin-1), CXCL1 (GROalpha), CX
293 The medical records of all patients with ME from December 1, 2010, to December 31, 2012, were rev
294 eported symptoms differentiate patients with ME/CFS from healthy controls under study conditions but
297 measures that best distinguish persons with ME/CFS from those in the comparison groups and detect su
299 y expert clinicians to care for persons with ME/CFS; 4) collect biospecimens for future hypothesis te
300 Optically guided single cell profiling with ME-SIMS is suitable for a range of cell sizes, from Aply
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。